Device Distal Extremities - Implants - Soft Tissue - Anchors

Distal Extremities Implants Soft Tissue Anchors

Payments companies reported to CMS as associated with Distal Extremities Implants Soft Tissue Anchors. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$3,445associated payments (2023-2025)
39clinicians with associated payments
1company reporting

By year

2023 $3,445

Payments reported as associated with Distal Extremities Implants Soft Tissue Anchors, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Orthopaedic Surgery $1,147
Hand Surgery $797
Foot & Ankle Surgery $663
Foot and Ankle Surgery $582
Sports Medicine (Orthopaedic Surgery) $153
Surgery of The Hand (Surgery) $60.65

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Distal Extremities Implants Soft Tissue Anchors

These are the largest totals companies reported as associated with Distal Extremities Implants Soft Tissue Anchors. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Steven Shin Los Angeles, CA Hand Surgery $311.39
Steven Lee Nyc, NY Sports Medicine (Orthopaedic Surgery) $152.86
Neil Tarabadkar Cumming, GA Orthopaedic Surgery $145.21
Steven Blackwood Marietta, GA Orthopaedic Surgery $145.20
David Heinsch Newnan, GA Orthopaedic Surgery $127.87
Edward Magur Chevy Chase, MD Foot and Ankle Surgery $124.45
Brittany Mayer Crofton, MD Foot & Ankle Surgery $124.45
David Macias Alexandria, VA Orthopaedic Surgery $124.45
Eric Harmelin Annapolis, MD Foot & Ankle Surgery $124.45
James Dupree Annapolis, MD Orthopaedic Surgery $124.45

Prescribed Distal Extremities Implants Soft Tissue Anchors?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.